FDA releases much-anticipated guidance around trial endpointsFDA/Regulatory, R&DThe FDA released guidelines Thursday in an attempt to clarify processes for assessing a drug candidate’s efficacy while simultaneously examining several endpoints. Read more October 21, 2022/by BioSpace https://www.pharmalive.com/wp-content/uploads/2022/02/FDA-Investigating-Possible-Death-Risk-Linked-to-TG-Therapeutics-Lymphoma-Drug-BioSpace-2-7-22.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2022-10-21 12:26:002022-10-21 12:26:00FDA releases much-anticipated guidance around trial endpoints
